Aqua lymphatic therapy in women who suffer from breast cancer treatment-related lymphedema: a randomized controlled study
- 1.5k Downloads
Lymphedema is an adverse effect of breast cancer surgery. Aqua lymphatic therapy (ALT) is a novel treatment for limb volume reduction.
The aim of this study was to examine whether ALT is a safe method and whether there are differences in adherence, limb volume, and quality of life between women who perform only self-management treatment and women who participate as well in ALT.
Design of the study was single-blind randomized clinical trial.
The setting was in a hydrotherapy pool, 1.2 m depth, and a temperature of 32–33°С.
Forty-eight women (56 ± 10 years), with a 12.8% lymphedema relative volume, participated in the study.
The control group was instructed to perform the self-management treatment. The study group joined a weekly session of ALT for 3 months in addition to the self-management therapy.
Adherence was assessed by a self-reported diary, limb volume by a water displacement device, quality of life by the Upper Limb Lymphedema Questionnaire (ULL27), prior to, and after the intervention period.
There was no episode of arm infection or aggravation in limb volume during the study period. ALT had a positive, statistically and clinically significant immediate effect on limb volume but no long-term effect was noted. The adherence rate to ALT was significantly higher than the adherence to self-management therapy. QOL improved in the study group.
ALT was found to be a safe method, with high adherence, in treating women who suffer from mild to moderate lymphedema. A significant immediate and insignificant long-term effect on limb volume was noted.
KeywordsAqua therapy Breast cancer Lymphedema
We express our deepest gratitude to Prof. Judith R. Casley-Smith, for her support in the development of the aqua lymphatic therapy. We thank the physical therapists, Anat Assa and Ilana Shneiderman, for helping with the assessment measurements.
- 4.Lymphoedema Framework (2006) Best practice for the management of lymphoedema. International consensus. MEP, LondonGoogle Scholar
- 9.International Society of Lymphology (2003) The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology 36:84–91Google Scholar
- 10.Passik SD, McDonald MV (1998) Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer 83(Suppl):2817–2820. doi: 10.1002/(SICI)1097-0142(19981215)83:12B+<2817::AID-CNCR32>3.0.CO;2-2 CrossRefPubMedGoogle Scholar
- 11.Casley-Smith JR, Casley Smith JR (1997) Modern treatment for lymphedema, 5th edn. The Lymphology Association of Australia, Adelaide Chapters 17, 21, 45Google Scholar
- 14.Boris M, Weindorf S, Lasinski B (1997) Persistence of lymphedema reduction after noninvasive complex lymphedema therapy. Oncology (Huntingt) 11:99–109; discussion 110, 113–114Google Scholar
- 15.Johansson K, Piller N (2007) Weight-bearing exercise and its impact on arm lymphedema. J Lymphoedema 2:15–18Google Scholar
- 18.Harris SR, Niesen-Vertommen SL (2000) Challenging the myth of exercise-induced lymphedema following breast cancer: a series of case reports. J Surg Oncol 74:95–98. doi: 10.1002/1096-9098(200006)74:2<95::AID-JSO3>3.0.CO;2-Q CrossRefPubMedGoogle Scholar
- 20.Johansson K, Tibe K, Kanne L, Skantz H (2004) Controlled physical training for arm lymphedema patients. Lymphology 37(suppl):37–39Google Scholar
- 21.Tidhar D, Shimony A, Drouin J (2004) Aqua lymphatic therapy for postsurgical breast cancer lymphedema. Rehab Oncol 22:6–14Google Scholar
- 24.Lasinski B, Boris M (2002) Comprehensive lymphedema: management results of a 5 year follow-up. Lymphology 35(suppl):301–304Google Scholar
- 27.Launois R, Mègnigbêto AC, Pocquet K, Alliot F (2002) A specific quality of life scale in upper limb lymphedema : the ULL-27 questionnaire. Lymphology 35(Suppl):181–187Google Scholar
- 28.SPSS (1999) Statistical Program for the Social Sciences Version 9.0. SPSS, Chicago, ILGoogle Scholar